Morepen Laboratories - Quaterly Results
Date: 28-10-2026
The Top line for the quarter ended September 2026 of Rs. 6779.98 millions up 83.48% from Rs. 3695.26 millions.Net Profit witnessed a 441.64% growth almost the double from Rs. 143.77 millions to Rs. 778.71 millions of same quarter last year.The company reported a good operating profit of 1184.55 millions compared to 325.76 millions of corresponding previous quarter.
| | Quarter ended | Year to Date | Year ended |
| | 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var |
| Sales | 6779.98 | 3695.26 | 83.48 | 12190.39 | 7608.10 | 60.23 | 16811.95 | 15545.35 | 8.15 |
| Other Income | 84.35 | 46.53 | 81.28 | 137.46 | 87.45 | 57.19 | 214.95 | 157.20 | 36.74 |
| PBIDT | 1184.55 | 325.76 | 263.63 | 2033.64 | 556.20 | 265.63 | 1335.74 | 1691.31 | -21.02 |
| Interest | 51.04 | 41.06 | 24.31 | 98.82 | 79.18 | 24.80 | 160.97 | 71.03 | 126.62 |
| PBDT | 1133.51 | 295.66 | 283.38 | 1934.82 | 487.98 | 296.50 | 1185.73 | 1620.28 | -26.82 |
| Depreciation | 96.99 | 107.02 | -9.37 | 176.78 | 185.81 | -4.86 | 293.08 | 244.42 | 19.91 |
| PBT | 1036.52 | 188.64 | 449.47 | 1758.04 | 302.17 | 481.80 | 892.65 | 1375.86 | -35.12 |
| TAX | 257.81 | 44.87 | 474.57 | 439.34 | 77.79 | 464.78 | 232.07 | 360.10 | -35.55 |
| Deferred Tax | 51.35 | 0.00 | 0.00 | 51.35 | 0.00 | 0.00 | 84.92 | 47.27 | 79.65 |
| PAT | 778.71 | 143.77 | 441.64 | 1318.70 | 224.38 | 487.71 | 660.58 | 1015.76 | -34.97 |
| Equity | 1095.84 | 1095.84 | 0.00 | 1095.84 | 1095.84 | 0.00 | 1095.84 | 1095.84 | 0.00 |
| PBIDTM(%) | 17.47 | 8.82 | 98.19 | 16.68 | 7.31 | 128.19 | 7.95 | 10.88 | -26.97 |
